MEASUREMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND DERIVATIVES CONTAINING THE U-PA SERINE PROTEASE DOMAIN

被引：0
|
作者：
VANKEER, L [1 ]
DECLERCK, PJ [1 ]
VERSTREKEN, M [1 ]
COLLEN, D [1 ]
机构：
[1] CATHOLIC UNIV LEUVEN,CTR THROMBOSIS & VASC RES,B-3000 LOUVAIN,BELGIUM
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1268 / 1268
页数：1
相关论文
共 50 条
  • [41] Auto-induction of urokinase type plasminogen activator (u-PA) in endothelial cells and monocytes
    Li, C
    Jiang, Y
    Tang, W
    Gurewich, V
    Liu, JN
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3070 - P3070
  • [42] MEASUREMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) WITH AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) BASED ON 3 MURINE MONOCLONAL-ANTIBODIES
    DARRAS, V
    THIENPONT, M
    STUMP, DC
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1986, 56 (03) : 411 - 414
  • [43] The charge interaction with Asp(355(194)) is critical for stabilizing the active conformation of urokinase-type plasminogen activator (u-PA)
    Liu, BF
    Wu, H
    Sun, Z
    Gurewich, V
    Zhu, D
    Liu, JN
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3077 - P3077
  • [44] Decrease in urokinase-type plasminogen activator (u-PA) levels in patients with non-insulin dependent diabetes mellitus
    Krekora, K
    Vitacolonna, E
    DiCastelnuovo, A
    DOrazio, A
    DeLucia, D
    Dooijewaard, G
    Capani, F
    Donati, MB
    Iacoviello, L
    FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (04): : 215 - 219
  • [45] Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB
    Cejková, J
    Cejka, C
    Zvárová, J
    ACTA HISTOCHEMICA, 2005, 107 (01) : 77 - 86
  • [46] Production of Urokinase-Type Plasminogen Activator (u-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Human Brain Tumours
    Y. Arai
    T. Kubota
    T. Nakagawa
    M. Kabuto
    K. Sato
    H. Kobayashi
    Acta Neurochirurgica, 1998, 140 : 377 - 386
  • [47] Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours
    Arai, Y
    Kubota, T
    Nakagawa, T
    Kabuto, M
    Sato, K
    Kobayashi, H
    ACTA NEUROCHIRURGICA, 1998, 140 (04) : 377 - 386
  • [48] High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
    Borgfeldt, C
    Casslén, B
    Liu, CL
    Hansson, S
    Lecander, I
    Åstedt, B
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (06) : 588 - 595
  • [49] THE KINETICS OF INHIBITION OF TISSUE-TYPE (T-PA) AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) BY 2 MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR 2 (PAI-2) - THE INFLUENCE OF FIBRIN
    THORSEN, S
    MADSEN, B
    RODER, M
    LECANDER, I
    ASTEDT, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 350 - 350
  • [50] BINDING OF UROKINASE-PLASMINOGEN ACTIVATOR (U-PA) TO MATRIGEL (TM) - EFFECTS ON PLASMINOGEN AND SINGLE-CHAIN-U-PA (SCU-PA) ACTIVATION
    VASUDEVAN, J
    GONIAS, SL
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1084 - 1084
12345